ACRO BIOMEDICAL CO., LTD. (ACBM) Gross margin 2017–2022
ACRO BIOMEDICAL CO., LTD. (ACBM) gross margin by fiscal year — reported gross profit divided by reported revenue.
21.3%FY2022 · since FY2017: 10.0% → 21.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 21.3% | -0.3 pp |
| FY2021 | 21.7% | -1.5 pp |
| FY2020 | 23.2% | +16.9 pp |
| FY2019 | 6.3% | -4.1 pp |
| FY2018 | 10.4% | +0.4 pp |
| FY2017 | 10.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice